Filing Details
BICYCLE THERAPEUTICS PLC (NASDAQ:BCYC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:BCYC
BICYCLE THERAPEUTICS PLC (BCYC) Files Quarterly Report for Q0
Filing Details BICYCLE THERAPEUTICS PLC (NASDAQ:BCYC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026. The Healthcare company…
Market Context
BICYCLE THERAPEUTICS PLC's stock currently trades at $4.01 with a market capitalization of $514.8M.
The 10-Q provides BICYCLE THERAPEUTICS PLC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for BICYCLE THERAPEUTICS PLC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BCYC Stock Page
Frequently Asked Questions
Where can I read BCYC's SEC filings?
Browse all filings on our BCYC SEC filings page.
What types of SEC filings does BICYCLE THERAPEUTICS PLC file?
Public companies like BICYCLE THERAPEUTICS PLC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
